Sept. 29
| 4:00 - 5:15 p.m. | Chasing the Sun: CTS-06 - COVID-19 IDSA Rapid Living Guidelines: Celebrations and Challenges | COVID-19 diagnostic testing guidelines | | Kim Hanson |
| Sept. 29 | 7:00 - 8:00p.m. | Chasing the Sun: CTS-08 - COVID-19 Update in Japan | | Yohei Doi | |
| Sept. 30 | 11:00 a.m. - 12:15 p.m. | 04 - Case-based Guidelines Session | Antimicrobial Resistant Gram-Negative Infections: A Case Based Approach | | Pranita Tamma |
| Sept. 30 | 11:00 a.m. - 12:15 p.m. | 04 - Case-based Guidelines Session | Molecular Diagnostics and Antigen Testing for COVID-19 | | Angela Caliendo |
| Sept. 30 | 11:00 a.m. - 12:15 p.m. | 05 - Diagnostic Clinical Cases | | | Chris Doern (panelist) |
| Sept. 30 | 11:00a.m. - 12:15p.m. | 12 - Hot issues in Enterococcus faecalis bacteremia/endocarditis (IE) | | Jose Miro | |
| Sept. 30 | 12:30 - 1:45 p.m. | 19 - Even More Bad Bugs (with Limited Drugs) | Difficult-to-treat Resistance (DTR) Pseudomonas aeruginosa | | Jessica Howard-Anderson |
| Sept. 30 | 12:30 - 1:45 p.m. | 21 - Cardiovascular implantable electronic device (CIED) infections | Microbiological Diagnosis: Role of Advanced Diagnostics | Jose Miro | Robin Patel |
| Sept. 30 | 12:30 - 1:45 p.m. | 26 - New Approaches to the Diagnosis of Lower Respiratory Tract Infections | Next-generation Sequencing Approaches to Lower Respiratory Tract Infections | | Patricia (Trish) Simner |
| Sept. 30 | 3:45 - 5:00 p.m. | 43 – What’s New with VRE | Treatment of VRE Bacteremia: What You Need to Know | Julia Messina | Jose Munita |
| Sept. 30 | 5:15 - 6:30 p.m. | 53 - Clinical Controversies in S. aureus Bacteremia | Optimal Dosing of Antibiotics for S.aureus Bacteremia in Specific Populations | Tom Holland | Amit Pai |
| Sept. 30 | 5:15 - 6:30 p.m. | 56 - Leading Teams During a Crisis | Managing & Maintaining Priorities | | Ebbing Lautenbach |
| Oct. 1 | 10:00 - 11:15 a.m. | 61 - Do breakpoints matter? The fungal story | Breakpoints in Yeast | | Mariana Castanheira |
| Oct. 1 | 11:30 a.m. - 12:45 p.m. | 750 - Challenging cases in Infectious Diseases | | Henry Chambers (interactive moderator) | |
| Oct. 1 | 11:30 a.m. - 12:45 p.m. | 79 - Top Practice-Changing Papers on Transplant ID | Top Practice-changing Papers in Solid Organ Transplant | | Judith Anesi |
| Oct. 1 | 11:30a.m. - 12:45p.m | 85 - Public-private partnerships to revive future antibiotic development and access | | Yohei Doi | |
| Oct. 1 | 2:45 - 4:00 p.m. | 90 - Therapeutic options for MDR gram-negatives | | Yohei Doi (interactive moderator) | David van Duin (panelist) |
| Oct. 1 | 2:45 - 4:00 p.m. | 92 - Successes in Outpatient Stewardship | | Sara Cosgrove | |
| Oct. 1 | 2:45 - 4:00p.m. | 95 - Big Beasts of Skin & Soft Tissue Infections | Gram-Positive Necrotizing Soft Tissue Infections | | Henry Chambers |
| Oct. 1 | 2:45 - 4:00p.m. | 101 - Update on natural and Prosthetic Vascular Graft Infections | | Jose Miro | |
| Oct. 1 | 2:45 - 4:00 p.m. | 102 - What's New in Orthopedic Infections: Bone Appetit! | Going Viral: Phage Therapy for Orthopedic Infections | | Gina Suh |
| Oct. 1 | 4:15 - 5:30p.m. | 110 – Infectious Disease Consulting for Businesses During COVID-19: Tales from the Front Line | COVID-19 Consulting for the Entertainment Industry | | Anthony Harris |
| Oct. 2 | 10:00 - 11:15 a.m.
| 127 - Pathogen-specific clinical trials: promise and practical considerations | Gram-Negative Trials: Lessons Learned | Yohei Doi | Thomas Lodise |
| Oct. 2 | 1:15 - 3:00 p.m. | 133 - Clinical Trials That May Change Your Practice | | Jessica Howard-Anderson, Tom Holland | |